By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
TWINJECT 0.3 Drug Profile
Email this page to a colleague
Which patents cover Twinject 0.3, and when can generic versions of Twinject 0.3 launch?
Twinject 0.3 is a drug marketed by Impax and is included in one NDA. There are two patents protecting this drug.
This drug has forty-three patent family members in fifteen countries.
The generic ingredient in TWINJECT 0.3 is epinephrine. There are twenty-one drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Twinject 0.3
A generic version of TWINJECT 0.3 was approved as epinephrine by BELCHER on July 29th, 2014.
Summary for TWINJECT 0.3
| International Patents: | 43 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,392 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TWINJECT 0.3 at DailyMed |
Recent Clinical Trials for TWINJECT 0.3
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Arthroplasty Foundation, Inc. | Phase 4 |
| University of Louisville | Phase 4 |
ATC Classes for TWINJECT 0.3
US Patents and Regulatory Information for TWINJECT 0.3
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax | TWINJECT 0.3 | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-001 | May 30, 2003 | DISCN | No | No | Get Started Free | Get Started Free | Y | Get Started Free | |||
| Impax | TWINJECT 0.3 | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-001 | May 30, 2003 | DISCN | No | No | Get Started Free | Get Started Free | Y | Get Started Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for TWINJECT 0.3
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3263161 | Get Started Free |
| South Africa | 200800888 | Get Started Free |
| Russian Federation | 2007124153 | Get Started Free |
| South Africa | 200704515 | Get Started Free |
| Japan | 5138811 | Get Started Free |
| World Intellectual Property Organization (WIPO) | 2012103130 | Get Started Free |
| European Patent Office | 1848490 | Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
